What is the success rate of stem cell therapy for Chronic Kidney Disease?
No universal cell-therapy success rate exists for CKD. Review cause, stage, albuminuria, eGFR trajectory, dialysis or transplant outcomes, cardiovascular events, comparator, medicines, adverse events and complete follow-up rather than a single creatinine result.
What the evidence shows for Chronic Kidney Disease
Evidence is investigational and must match CKD cause and stage, exact product, route, comparator and clinically meaningful kidney and cardiovascular outcomes. The NIDDK CKD management guide emphasises blood-pressure and diabetes control, prescribed medicines, monitoring, nutrition and preparation for kidney replacement therapy when needed. An experimental infusion must not delay those measures.
Am I a candidate? → · Chronic Kidney Disease: full overview → · Chronic Kidney Disease cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Chronic Kidney Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Chronic Kidney Disease cost? (2026)
- Chronic Kidney Disease stem cell therapy — your questions answered (2026)
- Chronic Kidney Disease: cell-therapy evidence by therapy class
- MSC vs HSCT for Chronic Kidney Disease: what the registries show